Accelerate Investment Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$341K Sell
940
-25
-3% -$8.56K 0.2% 84
2026
Q1
$339K Sell
965
-119
-11% -$42.4K 0.23% 68
2025
Q4
$355K Sell
1,084
-16
-1% -$5.08K 0.24% 63
2025
Q3
$310K Sell
1,100
-291
-21% -$84.4K 0.21% 74
2025
Q2
$388K Sell
1,391
-105
-7% -$29.7K 0.29% 56
2025
Q1
$466K Buy
1,496
+283
+23% +$83.6K 0.39% 48
2024
Q4
$316K Buy
1,213
+385
+46% +$114K 0.28% 59
2024
Q3
$267K Buy
+828
New +$271K 0.26% 61

Other funds holding AMGN

Accelerate Investment Advisors's AMGN Position: Q2 2026 in Review

Accelerate Investment Advisors reduced its Amgen (AMGN) stake by 2.6% in Q2 2026, selling an estimated $8.56K and leaving 940 shares worth $341K. The position accounts for 0.2% of the portfolio, ranked #84.

Accelerate Investment Advisors first reported a position in AMGN in Q3 2024 and has held it in 8 quarters since. The position peaked at $466K in Q1 2025. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Accelerate Investment Advisors held 940 shares of Amgen worth $341K as of Q2 2026.
  • Accelerate Investment Advisors sold 25 Amgen shares in Q2 2026, an estimated $8.56K.
  • Amgen made up 0.2% of Accelerate Investment Advisors's portfolio in Q2 2026, its #84 holding.
  • Accelerate Investment Advisors first reported a position in Amgen in Q3 2024 and has held it in 8 quarters since.
  • Accelerate Investment Advisors's Amgen position peaked at $466K in Q1 2025.
  • 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Accelerate Investment Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.